Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKYA

Akoya Biosciences (AKYA) Stock Price, News & Analysis

Akoya Biosciences logo

About Akoya Biosciences Stock (NASDAQ:AKYA)

Key Stats

Today's Range
$1.29
$1.29
50-Day Range
$1.12
$1.37
52-Week Range
$0.93
$3.42
Volume
N/A
Average Volume
416,191 shs
Market Capitalization
$64.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.38
Consensus Rating
Hold

Company Overview

Receive AKYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoya Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AKYA Stock News Headlines

AKYA Akoya Biosciences, Inc. - Seeking Alpha
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
See More Headlines

AKYA Stock Analysis - Frequently Asked Questions

Akoya Biosciences, Inc. (NASDAQ:AKYA) posted its quarterly earnings results on Monday, May, 12th. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.03. The business earned $16.64 million during the quarter, compared to analysts' expectations of $20.19 million. Akoya Biosciences had a negative net margin of 59.44% and a negative trailing twelve-month return on equity of 487.85%.

Akoya Biosciences (AKYA) raised $125 million in an initial public offering (IPO) on Friday, April 16th 2021. The company issued 6,600,000 shares at $18.00-$20.00 per share. J.P. Morgan, Morgan Stanley, Piper Sandler and Canaccord Genuity served as the underwriters for the IPO.

Top institutional investors of Akoya Biosciences include Geode Capital Management LLC (0.49%), JPMorgan Chase & Co. (0.28%), JBF Capital Inc. (0.24%) and Marshall Wace LLP (0.15%). Insiders that own company stock include Matthew Winkler, Garry PhD Nolan, Brian Mckelligon, John Frederick Ek, Frederic Pla and Joseph Driscoll.
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akoya Biosciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Broadcom (AVGO), Invesco QQQ (QQQ) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/12/2025
Today
9/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:AKYA
CIK
1711933
Fax
N/A
Employees
90
Year Founded
2015

Price Target and Rating

High Price Target
$5.00
Low Price Target
$1.08
Potential Upside/Downside
+84.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$55.37 million
Net Margins
-59.44%
Pretax Margin
-59.28%
Return on Equity
-487.85%
Return on Assets
-35.86%

Debt

Debt-to-Equity Ratio
10.12
Current Ratio
0.61
Quick Ratio
0.40

Sales & Book Value

Annual Sales
$79.96 million
Price / Sales
0.81
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.15 per share
Price / Book
8.60

Miscellaneous

Outstanding Shares
49,954,000
Free Float
46,307,000
Market Cap
$64.44 million
Optionable
Optionable
Beta
1.36

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:AKYA) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners